Recall Enforment Report D-1616-2014

Recall Details

Multi event Drug Recall Enforcement Report Class II voluntary initiated by Actavis Laboratories, FL, Inc., originally initiated on 04-24-2014 for the product Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-count bottle, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880, NDC 0591-0398-60, UPC 3 05910 39860 6. The product was recalled due to failed tablet/capsule specifications: recall due to complaints of split or broken tablets.. The product was distributed nationwide and the recall is currently terminated.

Recall Enforcement Reports

Recall Number Recall Initiation Date Report Date Recall Classification Quantity Product Description Recall Reason Status
D-1616-201404-24-201410-08-2014Class II36,538 bottlesDiclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-count bottle, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880, NDC 0591-0398-60, UPC 3 05910 39860 6.Failed Tablet/Capsule Specifications: Recall due to complaints of split or broken tablets.Terminated
D-1617-201404-24-201410-08-2014Class II6,041 bottlesDiclofenac Sodium and Misoprostol Delayed-Release Tablets, 50 mg/0.2 mg, 60-count bottle, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880, NDC 0591-0397-60, UPC 3 05910 39760 9.Failed Tablet/Capsule Specifications: Recall due to complaints of split or broken tablets.Terminated

Recalled Products

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
0591-0397Diclofenac Sodium And Misoprostol Diclofenac Sodium And MisoprostolTablet, Delayed ReleaseOralActavis Pharma, Inc.Human Prescription Drug
0591-0398Diclofenac Sodium And Misoprostol Diclofenac Sodium And MisoprostolTablet, Delayed ReleaseOralActavis Pharma, Inc.Human Prescription Drug